The DOI matches its Crossref record; 159 of the 159 references it cites were found in a registry or an index.
Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis
Open accessAbstract
Epithelial to mesenchymal transition (EMT) is a process during which cells lose their epithelial characteristics, for instance cell polarity and cell–cell contact, and gain mesenchymal properties, such as increased motility. In colorectal cancer (CRC), EMT is associated with an invasive or metastatic phenotype. In this review, we discuss recent studies exploring novel regulation mechanisms of EMT in CRC, including the identification of new CRC EMT regulators. Upregulation of inducers can promote EMT, leading to increased invasiveness and metastasis in CRC. These inducers can downregulate E-cadherin and upregulate N-cadherin and vimentin (VIM) through modulating EMT-related signaling pathways, for instance WNT/β-catenin and TGF-β, and EMT transcription factors, such as zinc finger E-box binding homeobox 1 (ZEB1) and ZEB2. In addition, several microRNAs (miRNAs), including members of the miR-34 and miR-200 families, are found to target mRNAs of EMT-transcription factors, for example ZEB1, ZEB2, or SNAIL. Downregulation of these miRNAs is associated with distant metastasis and advanced stage tumors. Furthermore, the role of EMT in circulating tumor cells (CTCs) is also discussed. Mesenchymal markers on the surface of EMT CTCs were found to be associated with metastasis and could serve as potential biomarkers for metastasis. Altogether, these studies indicate that EMT is orchestrated by a complicated network, involving regulators of different signaling pathways. Further studies are required to understand the mechanisms underlying EMT in CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
miR-429 mediates tumor growth and metastasis in colorectal cancer.
Han, Y., Zhao, Q., Zhou, J., & Shi, R. (2017) · Europe PMC (PubMed Central) · Cited by 37
RetractedEpithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
Singh, A., & Settleman, J. (2010) · Oncogene · doi:10.1038/onc.2010.215 · Cited by 2,545 · cited 1×
“Type 3 EMT is associated with invasive or metastatic phenotype [7].”
BackgroundDistant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Park, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272
Cohen, S. J., Punt, C. J. A., Iannotti, N., Saidman, B. H., Sabbath, K. D., Gabrail, N. Y., Picus, J., Morse, M., Mitchell, E., Miller, M. C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.8923 · Cited by 1,841
Labelle, M., Begum, S., & Hynes, R. O. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.009 · Cited by 1,833
Korpal, M., Lee, E. S., Hu, G., & Kang, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800074200 · Cited by 1,645
Epithelial-Mesenchymal Transitions
Kang, Y., & Massagué, J. (2004) · Cell · doi:10.1016/j.cell.2004.07.011 · Cited by 1,525
The Snail genes as inducers of cell movement and survival: implications in development and cancer
Barrallo-Gimeno, A., & Nieto, M. A. (2005) · Development · doi:10.1242/dev.01907 · Cited by 1,394
Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease
Acloque, H., Adams, M. S., Fishwick, K., Bronner-Fraser, M., & Nieto, M. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38019 · Cited by 1,370
Dissecting the metastatic cascade
Pantel, K., & Brakenhoff, R. H. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1370 · Cited by 1,281
Epithelial–mesenchymal plasticity in carcinoma metastasis
Tsai, J. H., & Yang, J. (2013) · Genes & Development · doi:10.1101/gad.225334.113 · Cited by 1,136
Brabletz, T., Jung, A., Reu, S., Porzner, M., Hlubek, F., Kunz-Schughart, L. A., Knuechel, R., & Kirchner, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171610498 · Cited by 1,049
EMT: When epithelial cells decide to become mesenchymal-like cells
Kalluri, R. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39675 · Cited by 952
MEF2: a central regulator of diverse developmental programs
Potthoff, M. J., & Olson, E. N. (2007) · Development · doi:10.1242/dev.008367 · Cited by 834 · cited 1×
“MEF2 plays central roles in the transmission of extracellular signals to the genome and in the activation of genetic programs that control cell differentiation, proliferation, morphogenesis, survival, and apoptosis of a wide range of cell types [104,105].”
BackgroundE-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.
Graff, J. R., Herman, J. G., Lapidus, R. G., Chopra, H., Xu, R., Jarrard, D. F., Isaacs, W. B., Pitha, P. M., Davidson, N. E., & Baylin, S. B. (1995) · PubMed · Cited by 796
Peinado, H., Ballestar, E., Esteller, M., & Cano, A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.1.306-319.2004 · Cited by 763
IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis
Rokavec, M., Öner, M. G., Li, H., Jackstadt, R., Jiang, L., Lodygin, D., Kaller, M., Horst, D., Ziegler, P. K., Schwitalla, S., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73531 · Cited by 753 · cited 5×
“Abbreviations: SIX1, sineoculis homeobox homolog 1; IL-6R, interleukin 6 receptor; ITGβ4, integrin β4; SOX4, SRY-Box 4; CYP7B1, cytochrome P450 family 7 subfamily B member 1; MMP-2, matrix metallopeptidase 2; DDB2, DNA damage-binding protein 2; CREB, cAMP response element binding; KLF4, kruppel like factor 4.”
BackgroundInfluentialThe two faces of transforming growth factor β in carcinogenesis
Roberts, A. B., & Wakefield, L. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633291100 · Cited by 747
MEF2: a calcium-dependent regulator of cell division, differentiation and death
McKinsey, T. A., Zhang, C. L., & Olson, E. N. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)02031-x · Cited by 687
Aigner, K., Dampier, B., Descovich, L., Mikula, M., Sultan, A., Schreiber, M., Mikulits, W., Brabletz, T., Strand, D., Obrist, P., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210508 · Cited by 617
miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions
Siemens, H., Jackstadt, R., Hünten, S., Kaller, M., Menssen, A., Götz, U., & Hermeking, H. (2011) · Cell Cycle · doi:10.4161/cc.10.24.18552 · Cited by 609
Gossett, L. A., Kelvin, D. J., Sternberg, E. A., & Olson, E. N. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.11.5022 · Cited by 601
Mechanisms, mechanics and function of epithelial–mesenchymal transitions in early development
Shook, D., & Keller, R. (2003) · Mechanisms of Development · doi:10.1016/j.mod.2003.06.005 · Cited by 582
Opposing LSD1 complexes function in developmental gene activation and repression programmes
Wang, J., Scully, K., Zhu, X., Cai, L., Zhang, J., Prefontaine, G. G., Krones, A., Ohgi, K. A., Zhu, P., Garcia-Bassets, I., et al. (2007) · Nature · doi:10.1038/nature05671 · Cited by 579
Liang, W.-C., Fu, W.-M., Wong, C.-W., Wang, Y., Wang, W.-M., Hu, G.-X., Zhang, L., Xiao, L.-J., Wan, D. C.-C., Zhang, J.-F., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4154 · Cited by 571
Gorges, T. M., Tinhofer, I., Drosch, M., Röse, L., Zollner, T. M., Krahn, T., & von Ahsen, O. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-178 · Cited by 565
Hur, K., Toiyama, Y., Takahashi, M., Balaguer, F., Nagasaka, T., Koike, J., Hemmi, H., Koi, M., Boland, C. R., & Goel, A. (2013) · Gut · doi:10.1136/gutjnl-2011-301846 · Cited by 533
The Transcriptional Repressor ZEB1 Promotes Metastasis and Loss of Cell Polarity in Cancer
Spaderna, S., Schmalhofer, O., Wahlbuhl, M., Dimmler, A., Bauer, K., Sultan, A., Hlubek, F., Jung, A., Strand, D., Eger, A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5682 · Cited by 532
Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer
Cohen, S. J., Punt, C. J. A., Iannotti, N., Saidman, B. H., Sabbath, K. D., Gabrail, N. Y., Picus, J., Morse, M. A., Mitchell, E., Miller, M. C., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn786 · Cited by 513
Sánchez-Tilló, E., Lázaro, A., Torrent, R., Cuatrecasas, M., Vaquero, E. C., Castells, A., Engel, P., & Postigo, A. (2010) · Oncogene · doi:10.1038/onc.2010.102 · Cited by 504
Guaita, S., Puig, I., Francı́, C., Garrido, M., Domı́nguez, D., Batlle, E., Sancho, E., Dedhar, S., de Herreros, A. G., & Baulida, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206400200 · Cited by 499
Li, D., & Roberts, R. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000838 · Cited by 495
Spaderna, S., Schmalhofer, O., Hlubek, F., Berx, G., Eger, A., Merkel, S., Jung, A., Kirchner, T., & Brabletz, T. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.06.016 · Cited by 476
Dong, C., Wu, Y., Yao, J., Wang, Y., Yu, Y., Rychahou, P. G., Evers, B. M., & Zhou, B. P. (2012) · Journal of Clinical Investigation · doi:10.1172/jci57349 · Cited by 464
Wnt-dependent Regulation of the E-cadherin Repressor Snail
Yook, J. I., Li, X.-Y., Ota, I., Fearon, E. R., & Weiss, S. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413878200 · Cited by 445
Polycomb Complex 2 Is Required for E-cadherin Repression by the Snail1 Transcription Factor
Herranz, N., Pasini, D., Díaz, V. M., Francí, C., Gutierrez, A., Dave, N., Escrivà, M., Hernandez-Muñoz, I., Di Croce, L., Helin, K., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00323-08 · Cited by 437
Postigo, A. A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg226 · Cited by 387
Thuault, S., Tan, E.-J., Peinado, H., Cano, A., Heldin, C.-H., & Moustakas, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802016200 · Cited by 365
Davalos, V, Moutinho, C., Villanueva, A., Boque, R., Silva, P., Carneiro, F., & Esteller, M. (2012) · Oncogene · doi:10.1038/onc.2011.383 · Cited by 351
A Noncanonical Frizzled2 Pathway Regulates Epithelial-Mesenchymal Transition and Metastasis
Gujral, T. S., Chan, M., Peshkin, L., Sorger, P. K., Kirschner, M. W., & MacBeath, G. (2014) · Cell · doi:10.1016/j.cell.2014.10.032 · Cited by 350
Palacios, F., Tushir, J. S., Fujita, Y., & D'Souza-Schorey, C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.1.389-402.2005 · Cited by 333
Wu, Z.-Q., Li, X.-Y., Hu, C. Y., Ford, M., Kleer, C. G., & Weiss, S. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205822109 · Cited by 305
Hwang, W., Yang, M., Tsai, M., Lan, H., Su, S., Chang, S., Teng, H., Yang, S., Lan, Y., Chiou, S., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.008 · Cited by 295
Lin, T., Ponn, A., Hu, X., Law, B. K., & Lu, J. (2010) · Oncogene · doi:10.1038/onc.2010.234 · Cited by 291
Shioiri, M., Shida, T., Koda, K., Oda, K., Seike, K., Nishimura, M., Takano, S., & Miyazaki, M. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603193 · Cited by 287
Pálmer, H. G., Larriba, M. J., García, J. M., Ordóñez-Morán, P., Peña, C., Peiró, S., Puig, I., Rodríguez, R., de la Fuente, R., Bernad, A., et al. (2004) · Nature Medicine · doi:10.1038/nm1095 · Cited by 286
HIF1A Overexpression Is Associated with Poor Prognosis in a Cohort of 731 Colorectal Cancers
Baba, Y., Nosho, K., Shima, K., Irahara, N., Chan, A. T., Meyerhardt, J. A., Chung, D. C., Giovannucci, E. L., Fuchs, C. S., & Ogino, S. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090972 · Cited by 285
ZEB represses transcription through interaction with the corepressor CtBP
Postigo, A. A., & Dean, D. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6683 · Cited by 275
Zhang, W., Shi, X., Peng, Y., Wu, M., Zhang, P., Xie, R., Wu, Y., Yan, Q., Liu, S., & Wang, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0129603 · Cited by 261
SET8 promotes epithelial–mesenchymal transition and confers TWIST dual transcriptional activities
Yang, F., Sun, L., Li, Q., Han, X., Lei, L., Zhang, H., & Shang, Y. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.364 · Cited by 258
Yokobori, T., Iinuma, H., Shimamura, T., Imoto, S., Sugimachi, K., Ishii, H., Iwatsuki, M., Ota, D., Ohkuma, M., Iwaya, T., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-0326 · Cited by 249
Snail promotes Wnt target gene expression and interacts with β-catenin
Stemmer, V, de Craene, B., Berx, G., & Behrens, J. (2008) · Oncogene · doi:10.1038/onc.2008.140 · Cited by 246
Epithelial–Mesenchymal Transitioned Circulating Tumor Cells Capture for Detecting Tumor Progression
Satelli, A., Mitra, A., Brownlee, Z., Xia, X., Bellister, S., Overman, M. J., Kopetz, S., Ellis, L. M., Meng, Q. H., & Li, S. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0894 · Cited by 242
Immune Escape and Survival Mechanisms in Circulating Tumor Cells of Colorectal Cancer
Steinert, G., Schölch, S., Niemietz, T., Iwata, N., García, S. A., Behrens, B., Voigt, A., Kloor, M., Benner, A., Bork, U., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1885 · Cited by 233
Smit, M. A., Geiger, T. R., Song, J.-Y., Gitelman, I., & Peeper, D. S. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01164-08 · Cited by 218
WU, Z.-H., WANG, X.-L., TANG, H.-M., JIANG, T., CHEN, J., LU, S., QIU, G.-Q., PENG, Z.-H., & YAN, D.-W. (2014) · Oncology Reports · doi:10.3892/or.2014.3186 · Cited by 214
Interaction with Suv39H1 is critical for Snail-mediated E-cadherin repression in breast cancer
Dong, C., Wu, Y., Wang, Y., Wang, C., Kang, T., Rychahou, P. G., Chi, Y.-I., Evers, B. M., & Zhou, B. P. (2013) · Oncogene · doi:10.1038/onc.2012.169 · Cited by 214
Tong, Z.-T., Cai, M.-Y., Wang, X.-G., Kong, L.-L., Mai, S.-J., Liu, Y.-H., Zhang, H.-B., Liao, Y.-J., Zheng, F., Zhu, W., et al. (2012) · Oncogene · doi:10.1038/onc.2011.254 · Cited by 210
Petrova, T. V., Nykänen, A., Norrmén, C., Ivanov, K. I., Andersson, L. C., Haglund, C., Puolakkainen, P., Wempe, F., von Melchner, H., Gradwohl, G., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.020 · Cited by 192
Tumor cell invasiveness correlates with changes in integrin expression and localization
Maschler, S., Wirl, G., Spring, H., Bredow, D. V., Sordat, I., Beug, H., & Reichmann, E. (2005) · Oncogene · doi:10.1038/sj.onc.1208423 · Cited by 190
FOXQ1 Is Overexpressed in Colorectal Cancer and Enhances Tumorigenicity and Tumor Growth
Kaneda, H., Arao, T., Tanaka, K., Tamura, D., Aomatsu, K., Kudo, K., Sakai, K., De Velasco, M. A., Matsumoto, K., Fujita, Y., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2161 · Cited by 187
FOXM1 (Forkhead box M1) in Tumorigenesis
(2013) · Advances in Cancer Research · doi:10.1016/b978-0-12-407190-2.00016-2 · Cited by 184
Tang, W., Zhu, Y., Gao, J., Fu, J., Liu, C., Liu, Y., Song, C., Zhu, S., Leng, Y., Wang, G., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.724 · Cited by 183
Voorneveld, P. W., Kodach, L. L., Jacobs, R. J., Liv, N., Zonnevylle, A. C., Hoogenboom, J. P., Biemond, I., Verspaget, H. W., Hommes, D. W., de Rooij, K., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.03.052 · Cited by 183
Kahlert, C., Lahes, S., Radhakrishnan, P., Dutta, S., Mogler, C., Herpel, E., Brand, K., Steinert, G., Schneider, M. A., Mollenhauer, M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2816 · Cited by 180
Zhang, H., Meng, F., Liu, G., Zhang, B., Zhu, J., Wu, F., Ethier, S. P., Miller, F., & Wu, G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2825 · Cited by 177
Zhu, W., Cai, M.-Y., Tong, Z.-T., Dong, S.-S., Mai, S.-J., Liao, Y.-J., Bian, X.-W., Lin, M. C., Kung, H.-F., Zeng, Y.-X., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300207 · Cited by 177
Yue, B., Qiu, S., Zhao, S., Liu, C., Zhang, D., Yu, F., Peng, Z., & Yan, D. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13206 · Cited by 175
Current treatment for colorectal liver metastases
Misiakos, E. P. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i36.4067 · Cited by 170
GDF15 promotes EMT and metastasis in colorectal cancer
Li, C., Wang, J., Kong, J., Tang, J., Wu, Y., Xu, E., Zhang, H., & Lai, M. (2016) · Oncotarget · doi:10.18632/oncotarget.6205 · Cited by 170
SNAIL and miR‐34a feed‐forward regulation of ZNF281/ZBP99 promotes epithelial–mesenchymal transition
Hahn, S., Jackstadt, R., Siemens, H., Hünten, S., & Hermeking, H. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.236 · Cited by 165
Jung, H., Lee, K., Park, S. J., Park, J., Jang, Y.-S., Choi, S.-Y., Jung, J.-G., Jo, K., Park, D. Y., Yoon, J.-H., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210914 · Cited by 157
Sun, Y., Shen, S., Liu, X., Tang, H., Wang, Z., Yu, Z., Li, X., & Wu, M. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1950-x · Cited by 152
Meng, X., Wu, J., Pan, C., Wang, H., Ying, X., Zhou, Y., Yu, H., Zuo, Y., Pan, Z., Liu, R., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.04.004 · Cited by 138
Identification of STRAP, a Novel WD Domain Protein in Transforming Growth Factor-β Signaling
Datta, P. K., Chytil, A., Gorska, A. E., & Moses, H. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.34671 · Cited by 136
Self-citationMicroRNAs in colorectal carcinoma - from pathogenesis to therapy
Chi, Y., & Zhou, D. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0320-4 · Cited by 136
Li, L., Li, X., Zhang, X., Lv, Z., He, G., Zhao, W., Ren, X., Li, Y., Bian, X., Liao, W., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.11.033 · Cited by 135
MicroRNA-192 suppresses liver metastasis of colon cancer
Geng, L., Chaudhuri, A., Talmon, G. A., Wisecarver, J. L., Are, C., Brattain, M. G., & Wang, J. (2013) · Oncogene · doi:10.1038/onc.2013.478 · Cited by 130
Qi, L., Sun, B., Liu, Z., Cheng, R.-F., Li, Y., & Zhao, X. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-014-0107-4 · Cited by 128
Li, Q., Liang, X., Wang, Y., Meng, X., Xu, Y., Cai, S., Wang, Z., Liu, J., & Cai, G. (2016) · Scientific Reports · doi:10.1038/srep27157 · Cited by 121
Sporadic colorectal cancer: microbial contributors to disease prevention, development and therapy
Drewes, J. L., Housseau, F., & Sears, C. L. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.189 · Cited by 121
Zhao, S., Venkatasubbarao, K., Lazor, J. W., Sperry, J. C., Jin, C., Cao, L., & Freeman, J. W. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5123 · Cited by 120
Lu, M., Huang, C., Pan, M., Chen, H., & Hung, W. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0832 · Cited by 120
miR-132 inhibits colorectal cancer invasion and metastasisviadirectly targeting ZEB2
Zheng, Y.-B., Luo, H.-P., Shi, Q., Hao, Z.-N., Ding, Y., Wang, Q.-S., Li, S.-B., Xiao, G.-C., & Tong, S.-L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i21.6515 · Cited by 118
Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer
Wallin, U., Glimelius, B. L. G., Jirström, K., Darmanis, S., Nong, R. Y., Pontén, F., Johansson, C., Påhlman, L., & Birgisson, H. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.112 · Cited by 118
Yang, C., Chen, H., Tan, G., Gao, W., Cheng, L., Jiang, X., Li, Y., & Tan, Y. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.07.004 · Cited by 116
Ferraro, A., Kontos, C. K., Boni, T., Bantounas, I., Siakouli, D., Kosmidou, V., Vlassi, M., Spyridakis, Y., Tsipras, I., Zografos, G., et al. (2014) · Epigenetics · doi:10.4161/epi.26842 · Cited by 111 · cited 4×
“miR-200 family P53/ZEB1/SIX1 ZEB1, ZEB2 [125,126] miR-429 P53/ZEB1/SIX1 HOXA5 [159] miR-34a SNAIL, ZEB1, IL-6/STAT3 SLUG, ZEB1, IL-6R [134,135] miR-9 N/A E-Cadherin [58] miR-21 AP-1/ETS1 ITGβ4 [150] miR-138 N/A TWIST2 [137] miR-132 N/A ZEB2 [131] miR-30b N/A SIX1 [139] miR-598 N/A JAG1/Notch2 [141] miR-4775 N/A TGFβ […”
BackgroundInfluentialKim, S., Kang, H. Y., Nam, E.-H., Choi, M. S., Zhao, X.-F., Hong, C. S., Lee, S. E., Lee, J. H., & Park, Y. K. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq024 · Cited by 111
Saad, S., Stanners, S. R., Yong, R., Tang, O., & Pollock, C. A. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.03.016 · Cited by 110
Guo, Q., Zhao, Y., Chen, J., Hu, J., Wang, S., Zhang, D., & Sun, Y. (2014) · Oncology Letters · doi:10.3892/ol.2014.2154 · Cited by 107
Snail1 Protein in the Stroma as a New Putative Prognosis Marker for Colon Tumours
Francı́, C., Gallén, M., Alameda, F., Baró, T., Iglesias, M., Virtanen, I., & de Herreros, A. G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005595 · Cited by 106
Long non-coding RNA TUG1 promotes colorectal cancer metastasis via EMT pathway
Wang, L., Zhao, Z., Feng, W., Ye, Z., Dai, W., Zhang, C., Peng, J., & Wu, K. (2016) · Oncotarget · doi:10.18632/oncotarget.10563 · Cited by 102
A Prospective Study of Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15) and Risk of Colorectal Cancer
Mehta, R. S., Song, M., Bezawada, N., Wu, K., García‐Albéniz, X., Morikawa, T., Fuchs, C. S., Ogino, S., Giovannucci, E. L., & Chan, A. T. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju016 · Cited by 98
N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer
Yan, X., YAN, L., Liu, S., Shan, Z., TIAN, Y., & Jin, Z. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3687 · Cited by 97
Gu, Y., Wang, Q., Guo, K., Qin, W., Liao, W., Wang, S., Ding, Y., & Lin, J. (2016) · The Journal of Pathology · doi:10.1002/path.4697 · Cited by 94
High expression of ZEB1 correlates with liver metastasis and poor prognosis in colorectal cancer
ZHANG, G.-J., Zhou, T., Tian, H., Liu, Z.-L., & Xia, S. (2012) · Oncology Letters · doi:10.3892/ol.2012.1026 · Cited by 92
Grandclément, C., Pallandre, J., Valmary‐Degano, S., Viel, E., Bouard, A., Balland, J., Rémy-Martin, J.-P., Simon, B., Rouleau, A., Boireau, W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020444 · Cited by 91
He, X., Chen, Z., Jia, M., & Zhao, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070858 · Cited by 91
Oncogenic Function of a Novel WD-Domain Protein, STRAP, in Human Carcinogenesis
Halder, S. K., Anumanthan, G., Maddula, R., Mann, J. R., Chytil, A., Gonzalez, A. L., Washington, M. K., Moses, H. L., Beauchamp, R. D., & Datta, P. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3261 · Cited by 91
Self-citationDown-regulation of miR-138 promotes colorectal cancer metastasis via directly targeting TWIST2
Long, L., Huang, G., Zhu, H., Guo, Y., Liu, Y., & Huo, J. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-275 · Cited by 90
FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer
Chu, X., Zhu, Z., Chen, L., Wang, J., Su, Q.-S., Yang, J., Lin, Y., Xue, L., Liu, X.-B., & Mo, X. (2012) · Acta Histochemica · doi:10.1016/j.acthis.2012.01.002 · Cited by 88
miR-320a suppresses colorectal cancer progression by targeting Rac1
Zhao, H., Dong, T., Zhou, H., Wang, L., Huang, A., Feng, B., Quan, Y., Jin, R., Zhang, W., Sun, J., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt378 · Cited by 86
Lu, M., Liu, Z., Li, B., Wang, G., Li, D., & Zhu, Y. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2252-y · Cited by 86
Weng, W., Okugawa, Y., Toden, S., Toiyama, Y., Kusunoki, M., & Goel, A. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0360 · Cited by 81
miR-598 inhibits metastasis in colorectal cancer by suppressing JAG1/Notch2 pathway stimulating EMT
Chen, J., Zhang, H., Chen, Y., Qiao, G., Jiang, W., Ni, P., Liu, X., & Ma, L. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.01.022 · Cited by 81
Wang, B., Li, W., Liu, H., Yang, L., Liao, Q., Cui, S., Wang, H., & Zhao, L. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.304 · Cited by 80
Liu, C.-W., Li, C.-H., Peng, Y., Cheng, Y., Chen, H., Liao, P.-L., Kang, J., & Yeng, M.-H. (2014) · Oncotarget · doi:10.18632/oncotarget.2006 · Cited by 79
Santoyo‐Ramos, P., Likhatcheva, M., García-Zepeda, E. A., Castañeda‐Patlán, M. C., & Robles‐Flores, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112580 · Cited by 79
García‐Palmero, I., Torres, S., Bartolomé, R. A., Peláez‐García, A., Larriba, M. J., López-Lucendo, M. F., Peña, C., Escudero-Paniagua, B., Múñoz, A., & Casal, J. I. (2016) · Oncogene · doi:10.1038/onc.2016.57 · Cited by 79
Zhao, S., Sun, H., Jiang, W., Mi, Y., Zhang, D., Wen, Y., Cheng, D., Tang, H., Wu, S., Yu, Y., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0585-z · Cited by 79
Su, L., Luo, Y., Yang, Z., Yang, H. J., Yao, C., Cheng, F., Shan, J., Chen, J., Li, F., Liu, L., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0246 · Cited by 78
Hu, F., Min, J., Cao, X., Liu, L., Ge, Z., Hu, J., & Li, X. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.04.055 · Cited by 76
MicroRNA-335 inhibits invasion and metastasis of colorectal cancer by targeting ZEB2
Sun, Z., Zhang, Z., Liu, Z., Qiu, B., Liu, K., & Dong, G. (2014) · Medical Oncology · doi:10.1007/s12032-014-0982-8 · Cited by 73
Galván, J. A., Stüssi‐Helbling, M., Koelzer, V. H., Tschan, M. P., Berger, M. D., Hädrich, M., Schnüriger, B., Karamitopoulou, E., Dawson, H., Inderbitzin, D., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2716 · Cited by 72
Loss of E-Cadherin Expression Is Associated with a Poor Prognosis in Stage III Colorectal Cancer
Yun, J.-A., Kim, S., Hong, H. K., Yun, S. H., Kim, H. C., Chun, H.-K., Cho, Y. B., & Lee, W. Y. (2014) · Oncology · doi:10.1159/000360794 · Cited by 72
Li, Q., Wu, J., Wei, P., Xu, Y., Zhuo, C., Wang, Y., Li, D., & Cai, S. (2015) · Europe PMC (PubMed Central) · Cited by 70
Guo, Y.-H., Wang, L.-Q., Li, B., Xu, H. M., Yang, J.-H., Zheng, L.-S., Yu, P., Zhou, A., Zhang, Y., Xie, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9893 · Cited by 69
TWIST1 Is Expressed in Colorectal Carcinomas and Predicts Patient Survival
Gómez, I., Peña, C., Herrera, M., Muñoz, C., Larriba, M. J., García‐Barberán, V., Domínguez, G., Silva, J., Rodríguez, R., de Herreros, A. G., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018023 · Cited by 68
Sànchez‐Tilló, E., de Barrios, O., Siles, L., Amendola, P. G., Darling, D. S., Cuatrecasas, M., Castells, A., & Postigo, A. A. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2675 · Cited by 68
FMNL2 Enhances Invasion of Colorectal Carcinoma by Inducing Epithelial-Mesenchymal Transition
Li, Y., Zhu, X., Zeng, Y., Wang, J., Zhang, X., Ding, Y., & Li, L. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0081 · Cited by 68
Zhang, X., Zhang, L., Du, Y., Zheng, H., Zhang, P., Sun, Y., Wang, Y., Chen, J., Ding, P., Wang, N., et al. (2016) · Oncogene · doi:10.1038/onc.2016.249 · Cited by 67
miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1
Chen, M. L., Liang, L. S., & Wang, X. K. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9463-7 · Cited by 66
MicroRNA-206 functions as a tumor suppressor in colorectal cancer by targeting FMNL2
Ren, X., He, G., Li, X. M., Men, H., Yi, L., Lu, G., Xin, S., Wu, P., Li, Y., Liao, W., et al. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-015-2053-8 · Cited by 66
TUSC3 Loss Alters the ER Stress Response and Accelerates Prostate Cancer Growth in vivo
Horak, P., Tomasich, E., Vaňhara, P., Vašíčková, K., Anees, M., Marhold, M., Lemberger, C. E., Gerschpacher, M., Horvat, R., Sibilia, M. C., et al. (2014) · Scientific Reports · doi:10.1038/srep03739 · Cited by 65
Expression and prognostic value of transcription factor PROX1 in colorectal cancer
Skog, M. S., Bono, P., Lundin, M., Lundin, J. E., Louhimo, J. M., Linder, N., Petrova, T. V., Andersson, L. C., Joensuu, H., Alitalo, K. K., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.297 · Cited by 64
TMPRSS4: an emerging potential therapeutic target in cancer
de Aberasturi, A. L., & Calvo, A. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.403 · Cited by 64
Matsuda, S., Katsumata, R., Okuda, T., Yamamoto, T., Miyazaki, K., Senga, T., Machida, K., Thant, A. A., Nakatsugawa, S., & Hamaguchi, M. (2000) · PubMed · Cited by 64
miR-30bregulates migration and invasion of human colorectal cancer via SIX1
Zhao, H., Xu, Z., Qin, H., Gao, Z., & Gao, L. (2014) · Biochemical Journal · doi:10.1042/bj20131535 · Cited by 60
Presence of Twist1-Positive Neoplastic Cells in the Stroma of Chromosome-Unstable Colorectal Tumors
Celesti, G., Caro, G. D., Bianchi, P. P., Grizzi, F., Basso, G., Marchesi, F., Doni, A., Marra, G., Roncalli, M. G., Mantovani, A., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.05.011 · Cited by 60
TMPRSS4 regulates levels of integrin α5 in NSCLC through miR-205 activity to promote metastasis
Larzábal, L., de Aberasturi, A. L., Redrado, M., Rueda, P., Rodríguez, M. J., Bodegas, M. E., Montuenga, L. M., & Calvo, A. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.761 · Cited by 60
Bao, Y., Lu, Y., Wang, X., Feng, W., Sun, X., Guo, H., Tang, C., Zhang, X., Shi, Q., & Yu, H. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0250-9 · Cited by 60
FMNL2 is a positive regulator of cell motility and metastasis in colorectal carcinoma
Zhu, X., Zeng, Y., Guan, J., Li, Y., Deng, Y., Bian, X., Ding, Y., & Li, L. (2011) · The Journal of Pathology · doi:10.1002/path.2871 · Cited by 57
Lee, S. C., Kim, O., Lee, S. K., & Kim, S. (2015) · Oncotarget · doi:10.18632/oncotarget.4354 · Cited by 57
Prognostic significance of E-cadherin expression in human colorectal cancer tissue
Mohri, Y. (1997) · Surgery Today · doi:10.1007/bf02388215 · Cited by 56
MicroRNA-34a targets FMNL2 and E2F5 and suppresses the progression of colorectal cancer
Lu, G.-F., Sun, Y., An, S., Xin, S., Ren, X., Zhang, D., Wu, P., Liao, W., Ding, Y., & Liang, L. (2015) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2015.06.014 · Cited by 55
MiR-675-5p supports hypoxia induced epithelial to mesenchymal transition in colon cancer cells
Costa, V., Dico, A. L., Rizzo, A. G., Raiata, F., Tripodi, M., Alessandro, R., & Conigliaro, A. (2017) · Oncotarget · doi:10.18632/oncotarget.14464 · Cited by 55
Mehta, R. S., Chong, D. Q., Song, M., Meyerhardt, J. A., Ng, K., Nishihara, R., Qian, Z., Morikawa, T., Wu, K., Giovannucci, E. L., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.038 · Cited by 54
CUI, F., Wang, S., Lao, I. W., Zhou, C., KONG, H., Bayaxi, N., Li, J., Chen, Q., Zhu, T., & Zhu, H. (2016) · Oncology Reports · doi:10.3892/or.2016.4834 · Cited by 54
Dexamethasone inhibits hypoxia-induced epithelial-mesenchymal transition in colon cancer
Kim, J. H. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i34.9887 · Cited by 53
Circulating tumour cells and the epithelial mesenchymal transition in colorectal cancer
Lim, S. H.-S., Becker, T. M., Chua, W., Ng, W. L., SOUZA, P. D., & Spring, K. J. (2014) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2014-202499 · Cited by 50
Vašíčková, K., Horak, P., Ešner, M., Souček, K., Pils, D., Anees, M., Tomasich, E., Dráfi, F., Sedláková, V., Hampl, A., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29502 · Cited by 50
The neuropilin 2 isoform NRP2b uniquely supports TGFβ-mediated progression in lung cancer
Gemmill, R. M., Nasarre, P., Nair-Menon, J. U., Cappuzzo, F., Landi, L. M., D’Incecco, A., Uramoto, H., Yoshida, T., Haura, E. B., Armeson, K. E., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aag0528 · Cited by 48
Wnt signaling through Snail1 and Zeb1 regulates bone metastasis in lung cancer.
Yang, X., Li, L., Huang, Q., Xu, W., Cai, X., Zhang, J., Yan, W., Song, D., Liu, T., Wang, Z., et al. (2015) · Europe PMC (PubMed Central) · Cited by 47
Xi, X., Zhuang, J., Teng, M., Xia, L., Yang, M., Liu, Q.-G., & Chen, J. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2624 · Cited by 42
Unraveling the Role of FOXQ1 in Colorectal Cancer Metastasis
Abba, M. L., Patil, N., Rasheed, S. A. K., Nelson, L. D., Mudduluru, G., Leupold, J. H., & Allgayer, H. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0024 · Cited by 38
Clinical significance of fibronectin expression in colorectal cancer
Nishimura, H., Kameoka, S., & Saito, N. (2008) · Molecular Medicine Reports · doi:10.3892/mmr.1.1.77 · Cited by 36
Anumanthan, G., Halder, S. K., Friedman, D. B., & Datta, P. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1599 · Cited by 36
Self-citationYuan, G., Zhang, B., Yang, S., Jin, L., Datta, A., Bae, S., Chen, X., & Datta, P. K. (2016) · Oncotarget · doi:10.18632/oncotarget.7532 · Cited by 31
Self-citationZhang, A., Shen, Q., & Zhang, P. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s114609 · Cited by 30
Twist2 is a valuable prognostic biomarker for colorectal cancer
Yu, H. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i15.2404 · Cited by 29
The role of growth differentiation factor 15 in the pathogenesis of primary myelofibrosis
Uchiyama, T., Kawabata, H., Miura, Y., Yoshioka, S., Iwasa, M., Yao, H., Sakamoto, S., Fujimoto, M., Haga, H., Kadowaki, N., et al. (2015) · Cancer Medicine · doi:10.1002/cam4.502 · Cited by 25
Wang, Y., Wu, N., Sun, D., Sun, H., Tong, D., Liu, D., Pang, B., Su, L., Wei, J., Dai, J., et al. (2017) · Cancer Science · doi:10.1111/cas.13243 · Cited by 25
TUSC3 suppresses glioblastoma development by inhibiting Akt signaling
Jiang, Z., Guo, M., Zhang, X., Yao, L., Shen, J., Ma, G., Liu, L., Zhao, L., Xie, C., Liang, H., et al. (2016) · Tumor Biology · doi:10.1007/s13277-016-5072-4 · Cited by 18
Cited by
Exosomes: key players in cancer and potential therapeutic strategy
Dai, J., Su, Y., Zhong, S., Cong, L., Liu, B., Yang, J., Tao, Y., He, Z., Chen, C., & Jiang, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00261-0 · Cited by 1,186
MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer
Zhang, L., Liao, Y., & Tang, L. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1059-5 · Cited by 510
The Epithelial-to-Mesenchymal Transition in Cancer
Roche, J. (2018) · Cancers · doi:10.3390/cancers10020052 · Cited by 435
Novel therapeutic strategies: targeting epithelial–mesenchymal transition in colorectal cancer
Zhang, N., Ng, A. S., Cai, S., Li, Q., Yang, L., & Kerr, D. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00343-0 · Cited by 349
Azwar, S., Seow, H. F., Abdullah, M., Faisal Jabar, M., & Mohtarrudin, N. (2021) · Biology · doi:10.3390/biology10090854 · Cited by 173
Metadata
- Authors
- Vu, T., & Datta, P.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2017-12-16
- Volume
- 9
- Issue
- 12
- Pages
- 171
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W2779263916
- Cited by
- 496
- References
- 159
- FWCI
- 15.19
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.